Released Jun 14, 2013, after the close
10-Q filed Jun 14, 2013, 45 days after period end · 0001354488-13-003485
Q2 2013 · 10-Q
Revenue—
Net Income$1.39M$1.39M +16.8% vs Q2 2012+31.7% vs Q1 2013
EPS Diluted$0.06$0.06 +13.5% vs Q2 2012+28.3% vs Q1 2013
Gross Profit$3,121,625+30.3%
Operating Income$1,747,714+22.6%
Operating Cash Flow$1,519,758N/M
Free Cash Flowderived$1,501,480N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Net Income | $1.39M | $1.19M | $479.69K |
| EPS Diluted | $0.06 | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR